SPUR THERAPEUTICS

spur-therapeutics-logo

Spur Therapeutics is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.

#People #Financial #Website #More

SPUR THERAPEUTICS

Industry:
Biotechnology Health Care Medical

Founded:
2024-01-01

Address:
Stevenage, Herefordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.spurtherapeutics.com

Total Employee:
101+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
50 M USD



Current Advisors List

chris-hollowood_image

Chris Hollowood Board Member @ Spur Therapeutics
Board_member
2024-06-01

Acquisitions List

Date Company Article Price
2024-06-17 Freeline Freeline acquired by Spur Therapeutics N/A
2024-06-17 SwanBio Therapeutics SwanBio Therapeutics acquired by Spur Therapeutics N/A

Investors List

syncona-partners-llp_image

Syncona Partners LLP

Syncona Partners LLP investment in Private Equity Round - Spur Therapeutics

Official Site Inspections

http://www.spurtherapeutics.com

  • Host name: 23.185.0.4
  • IP address: 23.185.0.4
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Spur Therapeutics"

Spur Therapeutics | Toward Moreโ„ข

Spur Therapeutics is a clinical-stage biotech that optimizes every component of its gene therapy candidates to change the course of diseasesโ€”and change lives.See details»

Spur Therapeutics - Crunchbase Company Profile & Funding

Organization. Spur Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. Spur Therapeutics is a clinical-stage biotechnology โ€ฆSee details»

Spur Therapeutics - LinkedIn

Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions.See details»

Spur Therapeutics Company Overview, Contact Details

Jun 17, 2024 Broad Therapeutic Focus Spur Therapeutics is expanding its pipeline beyond rare diseases to target more widespread conditions like Parkinson's and dementia, providing a โ€ฆSee details»

Spur Therapeutics - Funding, Financials, Valuation & Investors

Jun 17, 2024 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 17, 2024: โ€ฆSee details»

SPR Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +1 844 378 9108 SPRA Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary โ€ฆSee details»

SPR Therapeutics - Overview, News & Similar companies - ZoomInfo

Jan 31, 2024 SPR Therapeutics contact info: Phone number: (844) 378-9108 Website: www.sprtherapeutics.com What does SPR Therapeutics do? SPR Therapeutics is a medical โ€ฆSee details»

Creation of Spur Therapeutics - PharmiWeb.com

Jun 17, 2024 Syncona Limited Creation of Spur Therapeutics 17 June 2024 โ€ข Freeline acquires SwanBio to create a new company, Spur Therapeutics, combining two of Synconaโ€™s clinical โ€ฆSee details»

Creation of Spur Therapeutics โ€“ Company Announcement - FT.com

Jun 17, 2024 [1] The 31 December 2023 valuation of SwanBio (£74.6m) and Freeline (£20.5m), pro-rata for the movement in share price to the acquisition date and the consideration paid for โ€ฆSee details»

Spur Therapeutics (Formerly Freeline) Announces New Name

Jun 17, 2024 With a mission to redefine what gene therapy can do, Spur is optimizing every component of its product candidates to develop a new generation of gene therapiesSee details»

Syncona Unveils Spur Therapeutics for Gene Therapy Advancements

Jun 17, 2024 Syncona Shs GBP (GB:SYNC) has released an update.Syncona Limited has announced the creation of Spur Therapeutics through the acquisition of SwanBio by Freeline, โ€ฆSee details»

Spur Therapeutics | Clinical companies | Portfolio - Syncona

Investment thesis. Spur has two potential first-in-class gene therapy programmes. Its lead programme is a highly differentiated gene therapy candidate, FLT201, for Gaucher disease โ€ฆSee details»

Spur Therapeutics (Formerly Freeline) Announces New Name and โ€ฆ

Jun 17, 2024 Spur today also announced its acquisition of SwanBio Therapeutics, which adds a potential first-in-class gene therapy program for adrenomyeloneuropathy (AMN), a devastating โ€ฆSee details»

SPR Therapeutics โ€“ SPRINT PNS System

The SPRINT PNS System is indicated for up to 60 days for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post โ€ฆSee details»

Working At SPR Therapeutics: Company Overview and Culture

Mar 14, 2024 www.sprtherapeutics.com. Organization Type. Private. CEO. Maria E. Bennett. SPRA Therapeutics is a medical device company that is commercializing pain treatments โ€ฆSee details»

SPR Therapeutics Named a Top Workplace for Second โ€ฆ

Jun 25, 2023 The Top Workplaces awards highlight companies based on employee feedback on a set of 15 culture driving factors that are deemed critical of the success of an organization. Of โ€ฆSee details»

Spur Therapeutics (Formerly Freeline) Announces New Name and โ€ฆ

Jun 17, 2024 With a mission to redefine what gene therapy can do, Spur is optimizing every component of its product candidates to develop a new generation of gene therapiesSee details»

SPR® Therapeutics Recognized as a Top Workplace in Northeast โ€ฆ

Jun 23, 2024 โ€“ Corporate culture remains a strength as the company experienced dynamic growth โ€“ Cleveland, Ohio โ€“ June 23, 2024 โ€“ SPR Therapeutics has been honored as a Top โ€ฆSee details»

SPR® Therapeutics Announces $85 Million in Additional Funding โ€ฆ

CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients โ€ฆSee details»

Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crainโ€™s ...

Nov 18, 2024 Please reach out to our Patient Support team by calling 1-844-378-9108 and selecting option 1 from the menu between 8:00 a.m. and 5:00 p.m. EST. If more convenient, โ€ฆSee details»

linkstock.net © 2022. All rights reserved